[{"data":1,"prerenderedAt":740},["ShallowReactive",2],{"project-data-healthcare-stats":3,"project-data-healthcare-queries":77,"project-data-healthcare-similarity":425,"project-data-healthcare-communities":476,"project-data-healthcare-community_index":659,"project-data-healthcare-drug_index":720},{"nodeCounts":4,"relCounts":28,"highlights":58},[5,8,11,14,17,20,23,26],{"label":6,"count":7},"Case",4307,{"label":9,"count":10},"Reaction",2701,{"label":12,"count":13},"Drug",2500,{"label":15,"count":16},"Therapy",1721,{"label":18,"count":19},"Manufacturer",136,{"label":21,"count":22},"Outcome",6,{"label":24,"count":25},"AgeGroup",5,{"label":27,"count":25},"ReportSource",[29,32,35,38,41,43,45,47,50,53,55],{"type":30,"count":31},"HAS_REACTION",21069,{"type":33,"count":34},"IS_CONCOMITANT",8393,{"type":36,"count":37},"PRESCRIBED",5441,{"type":39,"count":40},"RESULTED_IN",4461,{"type":42,"count":7},"FALLS_UNDER",{"type":44,"count":7},"REGISTERED",{"type":46,"count":7},"REPORTED_BY",{"type":48,"count":49},"IS_PRIMARY_SUSPECT",3830,{"type":51,"count":52},"IS_SECONDARY_SUSPECT",3616,{"type":54,"count":16},"RECEIVED",{"type":56,"count":57},"IS_INTERACTING",1,[59,62,65,67,69,71,74],{"label":60,"value":61},"Nodes",11381,{"label":63,"value":64},"Relationships",61453,{"label":66,"value":7},"Cases",{"label":68,"value":10},"Distinct reactions",{"label":70,"value":13},"Drugs",{"label":72,"value":73},"Top severe drug (REVLIMID)",218,{"label":75,"value":76},"Top manufacturer (PFIZER)",617,[78,87,104,113,133,148,156,176,246,284,321],{"id":79,"title":80,"description":81,"cypher":82,"columns":83,"rows":85,"count":57},"eda-nodes","Total nodes","Overall size of the restored FAERS-style graph.","MATCH (n)\nRETURN count(n) AS total_nodes;",[84],"total_nodes",[86],{"total_nodes":61},{"id":88,"title":89,"description":90,"cypher":91,"columns":92,"rows":94,"count":103},"eda-labels","Node labels","Eight entity types discovered via schema EDA.","CALL db.labels() YIELD label\nRETURN label\nORDER BY label;",[93],"label",[95,96,97,98,99,100,101,102],{"label":24},{"label":6},{"label":12},{"label":18},{"label":21},{"label":9},{"label":27},{"label":15},8,{"id":105,"title":106,"description":107,"cypher":108,"columns":109,"rows":111,"count":57},"eda-rels","Total relationships","Directed edge count across all relationship types.","MATCH ()-[r]->()\nRETURN count(r) AS total_relationships;",[110],"total_relationships",[112],{"total_relationships":64},{"id":114,"title":115,"description":116,"cypher":117,"columns":118,"rows":120,"count":132},"eda-rel-types","Relationship types","Eleven relationship types linking cases, drugs, reactions, and outcomes.","MATCH ()-[r]->()\nRETURN DISTINCT type(r) AS relationship_type\nORDER BY relationship_type;",[119],"relationship_type",[121,122,123,124,125,126,127,128,129,130,131],{"relationship_type":42},{"relationship_type":30},{"relationship_type":33},{"relationship_type":56},{"relationship_type":48},{"relationship_type":51},{"relationship_type":36},{"relationship_type":54},{"relationship_type":44},{"relationship_type":46},{"relationship_type":39},11,{"id":134,"title":135,"description":136,"cypher":137,"columns":138,"rows":140,"count":147},"eda-genders","Case genders","Distinct gender values on Case nodes.","MATCH (c:Case)\nWHERE c.gender IS NOT NULL\nRETURN DISTINCT c.gender AS gender\nORDER BY gender;",[139],"gender",[141,143,145],{"gender":142},"F",{"gender":144},"M",{"gender":146},"U",3,{"id":149,"title":68,"description":150,"cypher":151,"columns":152,"rows":154,"count":57},"eda-reactions","Unique adverse-reaction descriptions in the graph.","MATCH (r:Reaction)\nWHERE r.description IS NOT NULL\nRETURN count(DISTINCT r.description) AS distinct_reactions;",[153],"distinct_reactions",[155],{"distinct_reactions":10},{"id":157,"title":158,"description":159,"cypher":160,"columns":161,"rows":163,"count":22},"eda-outcomes","Outcome descriptions","Seriousness categories used on Outcome nodes.","MATCH (o:Outcome)\nWHERE o.outcome IS NOT NULL\nRETURN DISTINCT o.outcome AS outcome_description\nORDER BY outcome_description;",[162],"outcome_description",[164,166,168,170,172,174],{"outcome_description":165},"Congenital Anomaly",{"outcome_description":167},"Death",{"outcome_description":169},"Disability",{"outcome_description":171},"Hospitalization - Initial or Prolonged",{"outcome_description":173},"Life-Threatening",{"outcome_description":175},"Other Serious (Important Medical Event)",{"id":177,"title":178,"description":179,"cypher":180,"columns":181,"rows":184,"count":245},"analytics-top-reactions","Top 20 reactions","Most frequent adverse reactions across all cases.","MATCH (c:Case)-[:HAS_REACTION]->(r:Reaction)\nWHERE r.description IS NOT NULL\nRETURN r.description AS reaction, count(*) AS frequency\nORDER BY frequency DESC\nLIMIT 20;",[182,183],"reaction","frequency",[185,188,191,194,197,200,203,206,209,212,215,218,221,224,227,230,233,236,239,242],{"reaction":186,"frequency":187},"Fatigue",303,{"reaction":189,"frequency":190},"Product dose omission issue",285,{"reaction":192,"frequency":193},"Headache",272,{"reaction":195,"frequency":196},"Nausea",256,{"reaction":198,"frequency":199},"Pain",253,{"reaction":201,"frequency":202},"Dyspnoea",245,{"reaction":204,"frequency":205},"Pneumonia",229,{"reaction":207,"frequency":208},"Diarrhoea",219,{"reaction":210,"frequency":211},"Fall",198,{"reaction":213,"frequency":214},"Off label use",196,{"reaction":216,"frequency":217},"Pyrexia",184,{"reaction":219,"frequency":220},"Dizziness",178,{"reaction":222,"frequency":223},"Sinusitis",166,{"reaction":225,"frequency":226},"Urinary tract infection",158,{"reaction":228,"frequency":229},"Asthenia",150,{"reaction":231,"frequency":232},"Vomiting",146,{"reaction":234,"frequency":235},"Drug ineffective",144,{"reaction":237,"frequency":238},"Malaise",143,{"reaction":240,"frequency":241},"COVID-19",140,{"reaction":243,"frequency":244},"Weight decreased",129,20,{"id":247,"title":248,"description":249,"cypher":250,"columns":251,"rows":254,"count":283},"analytics-severe-drugs","Top drugs with severe outcomes","Drugs linked as primary\u002Fsecondary suspect to cases with Death, Life-Threatening, Disability, or Hospitalization.","MATCH (d:Drug)\u003C-[:IS_PRIMARY_SUSPECT|IS_SECONDARY_SUSPECT]-(c:Case)\nMATCH (c)-[:RESULTED_IN]->(o:Outcome)\nWHERE o.outcome IN $severe\nRETURN d.name AS drug_name, count(DISTINCT c) AS severe_cases\nORDER BY severe_cases DESC\nLIMIT 10;",[252,253],"drug_name","severe_cases",[255,257,260,263,266,269,271,274,277,280],{"drug_name":256,"severe_cases":73},"REVLIMID",{"drug_name":258,"severe_cases":259},"NIVOLUMAB",82,{"drug_name":261,"severe_cases":262},"ATEZOLIZUMAB",77,{"drug_name":264,"severe_cases":265},"HUMAN NORMAL IMMUNOGLOBULIN; LIQUID",66,{"drug_name":267,"severe_cases":268},"POMALYST",65,{"drug_name":270,"severe_cases":268},"DEXAMETHASONE",{"drug_name":272,"severe_cases":273},"CYCLOPHOSPHAMIDE",64,{"drug_name":275,"severe_cases":276},"CUVITRU",61,{"drug_name":278,"severe_cases":279},"REMODULIN",57,{"drug_name":281,"severe_cases":282},"Teduglutide",53,10,{"id":285,"title":286,"description":287,"cypher":288,"columns":289,"rows":292,"count":283},"analytics-manufacturers","Top manufacturers by drugs with side effects","Manufacturers ranked by distinct drugs appearing on their registered cases that have reactions.","MATCH (m:Manufacturer)-[:REGISTERED]->(c:Case)-[:HAS_REACTION]->(r:Reaction)\nMATCH (d:Drug)\u003C-[:IS_PRIMARY_SUSPECT|IS_SECONDARY_SUSPECT|IS_CONCOMITANT|IS_INTERACTING]-(c)\nRETURN m.manufacturerName AS manufacturer, count(DISTINCT d) AS drugs_with_side_effects\nORDER BY drugs_with_side_effects DESC\nLIMIT 10;",[290,291],"manufacturer","drugs_with_side_effects",[293,295,298,301,304,307,310,313,315,318],{"manufacturer":294,"drugs_with_side_effects":76},"PFIZER",{"manufacturer":296,"drugs_with_side_effects":297},"ROCHE",595,{"manufacturer":299,"drugs_with_side_effects":300},"CELGENE",452,{"manufacturer":302,"drugs_with_side_effects":303},"NOVARTIS",386,{"manufacturer":305,"drugs_with_side_effects":306},"TAKEDA",356,{"manufacturer":308,"drugs_with_side_effects":309},"ABBVIE",352,{"manufacturer":311,"drugs_with_side_effects":312},"BRISTOL MYERS SQUIBB",307,{"manufacturer":314,"drugs_with_side_effects":73},"JOHNSON AND JOHNSON",{"manufacturer":316,"drugs_with_side_effects":317},"GLAXOSMITHKLINE",200,{"manufacturer":319,"drugs_with_side_effects":320},"AMGEN",191,{"id":322,"title":323,"description":324,"cypher":325,"columns":326,"rows":329,"count":25},"analytics-pfizer","PFIZER top drugs and side effects","Leading PFIZER drugs by case count with a sample of distinct reaction descriptions.","MATCH (m:Manufacturer {manufacturerName: 'PFIZER'})-[:REGISTERED]->(c:Case)-[:HAS_REACTION]->(r:Reaction)\nMATCH (d:Drug)\u003C-[:IS_PRIMARY_SUSPECT|IS_SECONDARY_SUSPECT|IS_CONCOMITANT|IS_INTERACTING]-(c)\nWHERE r.description IS NOT NULL\nRETURN d.name AS drug_name,\n       collect(DISTINCT r.description)[0..20] AS side_effects,\n       count(DISTINCT c) AS case_count\nORDER BY case_count DESC\nLIMIT 5;",[252,327,328],"side_effects","case_count",[330,351,373,392,410],{"drug_name":331,"side_effects":332,"case_count":350},"LYRICA",[333,198,334,335,336,337,338,237,339,340,341,342,343,344,345,346,347,348,201,349],"Ageusia","Hypoacusis","Temporomandibular joint syndrome","Depressed level of consciousness","Intentional product use issue","Gingival disorder","Anosmia","Viral infection","Deafness","Dry mouth","Confusional state","Memory impairment","Toothache","Panic attack","Anxiety","Hallucination","Withdrawal syndrome",120,{"drug_name":352,"side_effects":353,"case_count":262},"GENOTROPIN",[354,355,356,357,358,359,360,361,362,363,364,365,366,367,368,369,370,371,372,189],"Device breakage","Drug dose omission by device","Product prescribing error","Device use error","Device issue","Device physical property issue","Product physical issue","Wrong technique in device usage process","Device mechanical issue","Device use issue","Device leakage","Device power source issue","Blindness","Device information output issue","Incorrect dose administered by device","Poor quality device used","Device malfunction","Incorrect dose administered","Product dispensing error",{"drug_name":374,"side_effects":375,"case_count":391},"IBRANCE",[189,356,376,377,378,213,379,380,381,382,383,207,384,385,386,387,388,237,389,390],"Neoplasm progression","Neutropenia","Anaemia","Thrombocytopenia","White blood cell count decreased","Foot fracture","Product complaint","Poor quality product administered","Blood count abnormal","Neutrophil count decreased","Dyspnoea exertional","Pulmonary embolism","Illness","Amnesia","Cerebrovascular accident",48,{"drug_name":393,"side_effects":394,"case_count":409},"XELJANZ XR",[395,396,397,198,337,398,240,399,400,401,210,402,403,404,405,406,343,407,408,388],"Arthralgia","Feeling abnormal","Rheumatoid arthritis","Peripheral swelling","Gout","Rotator cuff syndrome","Aphonia","Contusion","Muscle rupture","Hair growth abnormal","Musculoskeletal stiffness","Impaired healing","Angle closure glaucoma","Therapeutic response unexpected",47,{"drug_name":411,"side_effects":412,"case_count":424},"XELJANZ",[397,413,380,198,213,414,415,416,408,237,417,388,418,189,395,419,420,421,422,423],"Lymphocyte count decreased","Bronchitis","Hypokinesia","Autoimmune disorder","Spinal fracture","Pain in extremity","Joint swelling","Pruritus","Nasopharyngitis","Influenza","Localised infection",32,{"metric":426,"cutoff":427,"pairs":428},"JACCARD",0.2,[429,434,438,443,447,451,455,461,465,469],{"case1":430,"case2":431,"similarity":57,"numSharedReactions":57,"sampleReactions":432,"sharedDrugs":433},"111530912","158574932",[204],[256],{"case1":430,"case2":435,"similarity":57,"numSharedReactions":57,"sampleReactions":436,"sharedDrugs":437},"124902822",[204],[256],{"case1":439,"case2":440,"similarity":57,"numSharedReactions":57,"sampleReactions":441,"sharedDrugs":442},"111140142","147242912",[377],[256],{"case1":439,"case2":444,"similarity":57,"numSharedReactions":57,"sampleReactions":445,"sharedDrugs":446},"194926201",[377],[256],{"case1":430,"case2":448,"similarity":57,"numSharedReactions":57,"sampleReactions":449,"sharedDrugs":450},"164981372",[204],[256],{"case1":430,"case2":452,"similarity":57,"numSharedReactions":57,"sampleReactions":453,"sharedDrugs":454},"124977452",[204],[256],{"case1":456,"case2":457,"similarity":57,"numSharedReactions":57,"sampleReactions":458,"sharedDrugs":460},"109837324","125979602",[459],"Atrial fibrillation",[256,270],{"case1":439,"case2":462,"similarity":57,"numSharedReactions":57,"sampleReactions":463,"sharedDrugs":464},"147065782",[377],[256],{"case1":439,"case2":466,"similarity":57,"numSharedReactions":57,"sampleReactions":467,"sharedDrugs":468},"194955072",[377],[256],{"case1":470,"case2":471,"similarity":57,"numSharedReactions":57,"sampleReactions":472,"sharedDrugs":474},"112550422","126241282",[473],"Septic shock",[475,270,256],"Carfilzomib",{"communityCount":245,"intro":477,"communities":478},"Leiden communities summarize each patient sub-phenotype by case count, top genders, age groups, and adverse reactions. Strong demographic or reaction concentration suggests a clinically interpretable cluster for targeted safety surveillance.",[479,489,495,505,512,522,531,539,549,558,567,576,585,594,602,613,622,632,642,651],{"id":480,"size":481,"topGenders":482,"topAgeGroups":483,"topReactions":487,"commentary":488},15,743,[144,142,146],[484,485,486],"Elderly","Adult","Adolescent",[204,207,167,201,186],"Largest respiratory\u002FGI cluster — often older adults; surveillance for infection and GI events under immunosuppressive or oncology therapy.",{"id":245,"size":490,"topGenders":491,"topAgeGroups":492,"topReactions":493,"commentary":494},544,[142,144],[485,484,486],[222,192,186,240,189],"Respiratory\u002Finfection and adherence cluster (sinusitis, headache, fatigue, dose-omission).",{"id":496,"size":497,"topGenders":498,"topAgeGroups":499,"topReactions":500,"commentary":504},4,489,[142,144,146],[485,484,486],[501,502,216,204,503],"Sepsis","Febrile neutropenia","Acute kidney injury","Severe infection \u002F immunocompromised phenotype (sepsis, febrile neutropenia, cytokine-release–like signals).",{"id":506,"size":507,"topGenders":508,"topAgeGroups":509,"topReactions":510,"commentary":511},14,415,[142,144,146],[485,484,486],[198,234,219,210,213],"Non-specific AE \u002F polypharmacy-like cluster (pain, falls, dizziness, feeling abnormal).",{"id":513,"size":514,"topGenders":515,"topAgeGroups":516,"topReactions":517,"commentary":521},7,400,[142,144],[485,484,486],[518,519,198,347,520],"Alopecia","Prostate cancer","Psychological trauma","Oncology sub-phenotype (alopecia, cancer diagnoses, treatment-related trauma).",{"id":523,"size":524,"topGenders":525,"topAgeGroups":526,"topReactions":527,"commentary":530},19,368,[142,144,146],[485,484,486],[189,355,358,528,529],"Accidental exposure to product","Wrong technique in product usage process","Device \u002F medication-management phenotype (dose omission, device issues, technique errors).",{"id":22,"size":532,"topGenders":533,"topAgeGroups":534,"topReactions":535,"commentary":538},349,[142,144,146],[484,485,486],[536,503,537,186,213],"Chronic kidney disease","Renal failure","Renal sub-phenotype (CKD, AKI, renal failure).",{"id":283,"size":540,"topGenders":541,"topAgeGroups":542,"topReactions":543,"commentary":548},237,[142,144],[485,484,486],[544,545,546,547,354],"Product quality issue","No adverse event","Complication of device insertion","Complication of device removal","Device safety reporting cluster (product quality, insertion\u002Fremoval complications).",{"id":550,"size":551,"topGenders":552,"topAgeGroups":553,"topReactions":555,"commentary":557},12,180,[142,144],[484,485,554],"Child",[195,186,231,207,556],"Platelet count decreased","Common GI adverse-event cluster.",{"id":147,"size":559,"topGenders":560,"topAgeGroups":561,"topReactions":562,"commentary":566},179,[142,144],[485,484,486],[201,563,564,565,195],"Hypotension","Fluid retention","Chest pain","Cardiorespiratory severity cluster (dyspnoea, hypotension, fluid issues).",{"id":25,"size":568,"topGenders":569,"topAgeGroups":570,"topReactions":572,"commentary":575},85,[142,144],[485,484,571],"Infant",[573,216,574,231,195],"Alanine aminotransferase increased","Aspartate aminotransferase increased","Hepatotoxicity signal (ALT\u002FAST elevations).",{"id":577,"size":578,"topGenders":579,"topAgeGroups":580,"topReactions":581,"commentary":584},21,83,[142,144],[485,484,554],[189,207,243,582,583],"Hospitalisation","Dehydration","Sub-phenotype of 83 cases dominated by Product dose omission issue, Diarrhoea, Weight decreased.",{"id":586,"size":587,"topGenders":588,"topAgeGroups":589,"topReactions":590,"commentary":593},9,60,[142,144],[485,484,486],[591,592,420,201,195],"Rash","Urticaria","Sub-phenotype of 60 cases dominated by Rash, Urticaria, Pruritus.",{"id":595,"size":391,"topGenders":596,"topAgeGroups":597,"topReactions":598,"commentary":601},18,[144,142],[486,484,485],[502,216,599,600,231],"Tachycardia","Hypoxia","Sub-phenotype of 48 cases dominated by Febrile neutropenia, Pyrexia, Tachycardia.",{"id":603,"size":604,"topGenders":605,"topAgeGroups":606,"topReactions":607,"commentary":612},17,46,[142,144],[485,484,486],[608,609,610,611,189],"Hereditary angioedema","Inappropriate schedule of product administration","Therapy interrupted","Inability to afford medication","Rare-disease \u002F hereditary angioedema treatment cluster.",{"id":614,"size":615,"topGenders":616,"topAgeGroups":617,"topReactions":618,"commentary":621},16,27,[142,144],[485,484,554],[619,186,620,189,337],"Prescribed underdose","Progressive multifocal leukoencephalopathy","Sub-phenotype of 27 cases dominated by Prescribed underdose, Fatigue, Progressive multifocal leukoencephalopathy.",{"id":623,"size":624,"topGenders":625,"topAgeGroups":626,"topReactions":627,"commentary":631},2,25,[144,142,146],[485,484,486],[628,629,192,630,189],"Haemorrhage","Suicidal ideation","Mouth haemorrhage","Sub-phenotype of 25 cases dominated by Haemorrhage, Suicidal ideation, Headache.",{"id":633,"size":132,"topGenders":634,"topAgeGroups":635,"topReactions":636,"commentary":641},0,[144,142],[485,484],[637,638,639,234,640],"Product substitution issue","Product solubility abnormal","Foreign body in throat","Product odour abnormal","Sub-phenotype of 11 cases dominated by Product substitution issue, Product solubility abnormal, Foreign body in throat.",{"id":643,"size":586,"topGenders":644,"topAgeGroups":645,"topReactions":646,"commentary":650},13,[142,144],[484,485,486],[366,647,648,649,503],"Cholecystitis acute","Uveitis","Eye irritation","Vascular \u002F ocular complications cluster.",{"id":132,"size":586,"topGenders":652,"topAgeGroups":653,"topReactions":654,"commentary":658},[142,144],[485,486],[655,656,418,198,657],"Sickle cell anaemia with crisis","Back pain","Bone pain","Sub-phenotype of 9 cases dominated by Sickle cell anaemia with crisis, Back pain, Pain in extremity.",[660,663,666,669,672,675,678,681,684,687,690,693,696,699,702,705,708,711,714,717],{"id":480,"size":481,"label":661,"topReactions":662},"Pneumonia, Diarrhoea",[204,207,167,201,186],{"id":245,"size":490,"label":664,"topReactions":665},"Sinusitis, Headache",[222,192,186,240,189],{"id":496,"size":497,"label":667,"topReactions":668},"Sepsis, Febrile neutropenia",[501,502,216,204,503],{"id":506,"size":507,"label":670,"topReactions":671},"Pain, Drug ineffective",[198,234,219,210,213],{"id":513,"size":514,"label":673,"topReactions":674},"Alopecia, Prostate cancer",[518,519,198,347,520],{"id":523,"size":524,"label":676,"topReactions":677},"Product dose omission issue, Drug dose omission by device",[189,355,358,528,529],{"id":22,"size":532,"label":679,"topReactions":680},"Chronic kidney disease, Acute kidney injury",[536,503,537,186,213],{"id":283,"size":540,"label":682,"topReactions":683},"Product quality issue, No adverse event",[544,545,546,547,354],{"id":550,"size":551,"label":685,"topReactions":686},"Nausea, Fatigue",[195,186,231,207,556],{"id":147,"size":559,"label":688,"topReactions":689},"Dyspnoea, Hypotension",[201,563,564,565,195],{"id":25,"size":568,"label":691,"topReactions":692},"Alanine aminotransferase increased, Pyrexia",[573,216,574,231,195],{"id":577,"size":578,"label":694,"topReactions":695},"Product dose omission issue, Diarrhoea",[189,207,243,582,583],{"id":586,"size":587,"label":697,"topReactions":698},"Rash, Urticaria",[591,592,420,201,195],{"id":595,"size":391,"label":700,"topReactions":701},"Febrile neutropenia, Pyrexia",[502,216,599,600,231],{"id":603,"size":604,"label":703,"topReactions":704},"Hereditary angioedema, Inappropriate schedule of product administration",[608,609,610,611,189],{"id":614,"size":615,"label":706,"topReactions":707},"Prescribed underdose, Fatigue",[619,186,620,189,337],{"id":623,"size":624,"label":709,"topReactions":710},"Haemorrhage, Suicidal ideation",[628,629,192,630,189],{"id":633,"size":132,"label":712,"topReactions":713},"Product substitution issue, Product solubility abnormal",[637,638,639,234,640],{"id":643,"size":586,"label":715,"topReactions":716},"Blindness, Cholecystitis acute",[366,647,648,649,503],{"id":132,"size":586,"label":718,"topReactions":719},"Sickle cell anaemia with crisis, Back pain",[655,656,418,198,657],[721,723,724,725,727,728,729,730,731,732,733,735,736,737,739],{"name":256,"slug":256,"severeCases":73,"source":722},"severe",{"name":258,"slug":258,"severeCases":259,"source":722},{"name":261,"slug":261,"severeCases":262,"source":722},{"name":264,"slug":726,"severeCases":265,"source":722},"HUMAN_NORMAL_IMMUNOGLOBULIN_LIQUID",{"name":267,"slug":267,"severeCases":268,"source":722},{"name":270,"slug":270,"severeCases":268,"source":722},{"name":272,"slug":272,"severeCases":273,"source":722},{"name":275,"slug":275,"severeCases":276,"source":722},{"name":278,"slug":278,"severeCases":279,"source":722},{"name":281,"slug":281,"severeCases":282,"source":722},{"name":331,"slug":331,"caseCount":350,"source":734},"pfizer",{"name":352,"slug":352,"caseCount":262,"source":734},{"name":374,"slug":374,"caseCount":391,"source":734},{"name":393,"slug":738,"caseCount":409,"source":734},"XELJANZ_XR",{"name":411,"slug":411,"caseCount":424,"source":734},1784124926927]